Article
Apolipoprotein A-I(Milano): current perspectives.
Current opinion in lipidology - 1 Apr 2003
Chiesa Giulia, Sirtori Cesare R
Abstract excerpt
PURPOSE OF REVIEW: Strategies to increase HDL are among the major targets of clinical research in atherosclerosis prevention. The mutant apolipoprotein A-I(Milano) has been associated with a reduced incidence of coronary disease in carriers. Furthermore, recombinant apolipoprotein A-I(Milano) has displayed remarkable atheroprotective activities and the possibility of directly reducing the burden of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
